Stephen is a PhD Pharmacist (Queens University, Belfast) with 30+ years experience in Pharmaceutical product development. During his career he has worked with a number of large Pharma and Biotech companies including Sterling Winthrop, Sanofi, Chiroscience, Celltech, and UCB. He has experience with a wide range of dosage forms, (oral and injectable), drug delivery technologies and devices and established and led Pharmaceutical Development teams responsible for the successful development of a number of new chemical entities (NCEs) and antibody products with total peak annual sales in excess of $3Bn, including Oxaliplatin and Cimzia.